BioCentury
ARTICLE | Company News

Inflazyme management update

January 7, 2008 8:00 AM UTC

Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H), Richmond, B.C. Business: Inflammation, Neurology Resigned: Kevin Mullane as president and CEO; David Burgoyne as VP of business development; and John Langla...